Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Oxford Biomedica Appoints Frank Mathias as CEO (2022-11-22)
Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023. Dr Mathias brings world-cl...
Catalym Closes €50m Series C Led by Brandon Capital & Jeito (2022-11-22)
CatalYm today announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation from existing investors Forbion, Novartis Venture Fund, Vesal...
G1 Therapeutics Closes $50.05m Public Offering at $6.5/Share (2022-11-22)
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the closing of an underwritten public offering of 7,700,000 shares of its common stock at a public offering price of $6.50 per share. G1 Therapeutics received $50,050,000 in ...
Uniqure & CSL: FDA Approves Gene Therapy for Hemophilia B (2022-11-22)
> Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels > uniQure conducted the multi-year clinical development pro...
Fujifilm Invests $188m in Cell Culture Media Plant in RTP (2022-11-22)
> Fujifilm’s fifth media manufacturing site to be operated by FUJIFILM Irvine Scientific > Triples the company’s current capacity for liquid cell culture media production > Creates over 100 new positions, including bioprocessing engineers, manufacturing, produ...
Cambrex to Acquire Snapdragon Chemistry (2022-11-21)
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdra...
Merck & Co. to Acquire Imago BioSciences for $1.35b in Cash (2022-11-21)
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $3...
FogPharma Announces $178m Series D Financing Round (2022-11-21)
> Helicon polypeptide therapeutics are a new class of drugs designed to address the limitations of today’s precision medicines and ultimately achieve universal druggability > FOG-001, a first-in-class direct TCF-blocking ß-catenin inhibitor with potential applic...
Cradle Bio Emerges from Stealth with €5.5m in Seed Funding (2022-11-17)
> Cradle’s design platform makes it easy for everyone to start building products with biology instead of oil or animals, leveraging generative machine learning models to transform how biologists design and optimize proteins > Synthetic biology can generate envir...
Valneva Appoints Dipal Patel as Chief Commercial Officer (2022-11-17)
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dipal Patel as Chief Commercial Officer (CCO) and Management Board member. With this newly created role, Valneva strengthens its management team with a r...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]